Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Opioid analgesics

Pharmacists may need more comprehensive training in discussing opioid risks with patients, interviews reveal

Although pharmacists told study authors that they did not always feel comfortable discussing opioid risk, prescribers and patients viewed pharmacists as being the best healthcare professionals to convey this information.

Pharmacy prescription bag

Source: Lewis Houghton / Science Photo Library

Having interviewed 16 patients and paediatric caregivers, researchers found that only two had been told that the prescribed medicine was an opioid, or warned that opioids carry a risk of physical dependency

Pharmacists need better guidelines, training and interventions to inform patients about the potential risks of opioid medicines, the authors of a study published in Research in Social and Administrative Pharmacy (21 November 2019) have concluded[1].

Researchers carried out 35 interviews with people who had been involved in opioid prescribing, including ten pharmacists, nine prescribers, ten adult patients and six paediatric caregivers.

The interviews revealed that only two of the patients and caregivers had been told that the prescribed medicine was an opioid, or warned that opioids carry a risk of physical dependency.

The responses also showed that pharmacists were not always comfortable discussing the risks of opioids with patients, but prescribers and patients viewed pharmacists as being the best placed healthcare professionals to convey this information.

The researchers said their findings show that pharmacists’ behaviour was not aligned with prescribers’ and patients’ expectations, leading to missed opportunities in opioid communication.

“It is essential to identify practices to help pharmacists become more responsive to patient expectations and to develop training needed to prepare them to communicate information clearly and with confidence,” they concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207743

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.